Results 191 to 200 of about 1,969,573 (309)

“Hidden” Landscape of Prehistoric Burial Monuments: The Use of Remote Sensing in the Detection of Neolithic Long Barrows in Bohemia (Czech Republic)

open access: yesArchaeological Prospection, EarlyView.
ABSTRACT Neolithic long barrows are among the earliest monumental structures in Europe, yet in many parts of Central Europe their surface expression has been largely erased by long‐term agricultural activity. This study evaluates the potential of integrated remote sensing approaches for identifying and contextualizing long barrows and associated ...
Petr Krištuf   +5 more
wiley   +1 more source

Multi‐Method Geophysical Surveys Between and Around the Kerlescan and the Manio Megalithic Alignments in Carnac (Morbihan, France)

open access: yesArchaeological Prospection, EarlyView.
ABSTRACT The Carnac alignments in Morbihan (France) are among the most famous Neolithic sites of the world. Paradoxically, they have benefited little from a thorough renewal of archaeological data over the past century. There are many reasons for this, but it is mainly because the site has been regarded more as a monument to visit and protect than as ...
Guillaume Bruniaux   +6 more
wiley   +1 more source

Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm   +2 more
wiley   +1 more source

Erratum: Abnormally Low HbA1c Caused by Hemolytic Anemia, a Case Report and Literature Review

open access: yesBritish Journal of Biomedical Science
British Journal of Biomedical Science Production Office
doaj   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy